Migraine sufferers look elsewhere as Cierra buckles
The headache is over for medical device maker Cierra. Actually it’s all over. The Redwood City, Calif.-based company is out of business after failing to draft enough participants into a clinical trial of a catheter-based technology purported to reduce migraines, VentureWire reported. It takes $29 million in venture capital down with it from investors Delphi Ventures, Frazier Healthcare Ventures, Morgenthaler Ventures and Split Rock Partners.
Believing that migraines could be made less frequent by sealing a… Continue Reading